The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review

Human Psychopharmacology
Cesario BellantuonoMaria Giulia Martini

Abstract

The present study provides a comprehensive review of the existing literature on the safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and lactation. Studies published in English, reporting the use of SNRIs in pregnant and/or breastfeeding women, were identified by searching MEDLINE/Pubmed, PsycINFO, and EMBASE. Twenty-nine studies were included in the review. Altogether, the initial evidence coming from the reviewed studies suggests a lack of association between SNRIs and an increased risk of major congenital malformations. Conversely, exposure to SNRIs seems to be significantly associated with an increased risk of some perinatal complications. No neonatal adverse events emerged, so far, in the few studies concerning the safety of SNRIs during breastfeeding. Available data suggest that venlafaxine is relatively safe during pregnancy, in particular as far as major malformations are concerned, whereas considering the small number of studies published, no definitive conclusions can be drawn on its safety during breastfeeding. Because of the few studies so far published, the safety of duloxetine during pregnancy and breastfeeding remains to be well established.

References

Jun 27, 1998·British Journal of Clinical Pharmacology·K F IlettP Yapp
Dec 1, 2001·The American Journal of Psychiatry·V HendrickW A Dunn
Feb 19, 2002·British Journal of Clinical Pharmacology·Kenneth F IlettJonathan Rampono
Mar 24, 2004·The International Journal of Neuropsychopharmacology·Jonathan RamponoKenneth F Ilett
Oct 27, 2004·Reproductive Toxicology·Fusun YarisMesut Unsal
Jan 12, 2005·Journal of Clinical Psychopharmacology·Pär Hallberg, Viktoria Sjöblom
Jan 5, 2006·The American Journal of Psychiatry·Ada M LoughheadZachary N Stowe
Jun 17, 2006·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Gideon KorenBhushan Kapur
Sep 16, 2006·Journal of Clinical Psychopharmacology·Shaila MisriKristin Kendrick
Oct 19, 2006·Journal of Paediatrics and Child Health·Ravi K PakalapatiJulee Oei
Apr 18, 2007·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Judith AlderWolfgang Holzgreve
Nov 16, 2007·Journal of Clinical Psychopharmacology·Roland Lennestål, Bengt Källén
Mar 5, 2008·Pharmacoepidemiology and Drug Safety·Bengt Källén, Petra Otterblad Olausson
May 3, 2008·The American Journal of Psychiatry·Roy Eyal, Deborah Yaeger
Mar 27, 2009·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Adrienne EinarsonGideon Koren
May 21, 2009·Therapeutic Drug Monitoring·Nina BoucherLouise Beaulac-Baillargeon
Jul 18, 2009·The Journal of Clinical Psychiatry·D Jeffrey NewportZachary N Stowe
Aug 21, 2009·American Journal of Obstetrics and Gynecology·Ronit Calderon-MargalitMichelle A Williams
Sep 10, 2009·Birth Defects Research. Part A, Clinical and Molecular Teratology·Keele E WurstAndrew F Olshan
Oct 8, 2009·The Annals of Pharmacotherapy·Gerald G BriggsGuadalupe Padilla
Jun 2, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Hamid Reza Nakhai-PourAnick Bérard
Jul 6, 2010·Birth Defects Research. Part A, Clinical and Molecular Teratology·Adrienne Einarson, Gideon Koren
Aug 19, 2010·British Journal of Clinical Pharmacology·Chris J C HoppenbrouwersAdriaan Honig
Sep 14, 2010·Acta Psychiatrica Scandinavica·Y-B SchuelerS Weinmann
Sep 22, 2010·Neuropsychiatric Disease and Treatment·Siegfried Kasper, Gerald Pail
Mar 2, 2011·Archives of Women's Mental Health·Philip M BoyceKenneth F Ilett
Jun 8, 2011·Obstetrics and Gynecology·Heli MalmAnnukka Ritvanen
Sep 22, 2011·Obstetrics and Gynecology·Anna PupcoGideon Koren
Mar 7, 2012·Archives of General Psychiatry·Hanan El MarrounHenning Tiemeier
Apr 25, 2012·Social Psychiatry and Psychiatric Epidemiology·Matteo BalestrieriCesario Bellantuono
Dec 12, 2012·The Journal of Clinical Psychiatry·Adrienne EinarsonThomas R Einarson
Jan 3, 2013·Birth Defects Research. Part A, Clinical and Molecular Teratology·Kara N D PolenUNKNOWN National Birth Defects Prevention Study
Mar 9, 2013·International Journal of Medical Sciences·Sharon L HoogSherie A Dowsett
Apr 27, 2013·Pharmacoepidemiology and Drug Safety·Jennifer N LindUNKNOWN National Birth Defects Prevention Study
May 3, 2013·PloS One·Espen Jimenez-SolemHenrik Enghusen Poulsen
May 10, 2013·The Journal of Clinical Psychiatry·Sophie GrigoriadisLori E Ross

❮ Previous
Next ❯

Citations

Apr 22, 2016·Clinical Case Reports·Ana R AraújoRui Anjos
Dec 23, 2016·Obstetrical & Gynecological Survey·Salvatore Giovanni VitaleAntonio Bruno
Sep 21, 2018·The Nurse Practitioner·Debra A Scrandis
Dec 23, 2017·Advances in Therapy·Ariane StollenwerkDetlef von Zabern
Jan 20, 2018·CNS Spectrums·Michael Thomson, Verinder Sharma
Feb 23, 2020·Frontiers in Pharmacology·Ewa ObuchowiczTomasz Ludyga
May 11, 2017·Archives of Women's Mental Health·Kristen C StoneKevin E O'Grady
Jun 27, 2019·Pain Practice : the Official Journal of World Institute of Pain·Eleanor BlackApo Demirkol
Jan 3, 2019·American Journal of Therapeutics·Faruk Uguz
Aug 26, 2020·Revue neurologique·S de Gaalon, A Donnet
Jun 13, 2021·The American Journal of Nursing·Barbara Marie Alba
Jun 24, 2021·Therapeutic Advances in Psychopharmacology·Le Xiao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.